Merck Picks Up Another Win In Fosamax Bellwether
Jurors returned a verdict Friday in favor of Merck & Co. Inc. in one of a handful of bellwether cases alleging the company's osteoporosis drug Fosamax can cause bone rotting in...To view the full article, register now.
Already a subscriber? Click here to view full article